Oliver Planz

7.7k total citations · 1 hit paper
108 papers, 6.0k citations indexed

About

Oliver Planz is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Oliver Planz has authored 108 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Epidemiology, 56 papers in Immunology and 29 papers in Infectious Diseases. Recurrent topics in Oliver Planz's work include interferon and immune responses (45 papers), Influenza Virus Research Studies (41 papers) and Virology and Viral Diseases (26 papers). Oliver Planz is often cited by papers focused on interferon and immune responses (45 papers), Influenza Virus Research Studies (41 papers) and Virology and Viral Diseases (26 papers). Oliver Planz collaborates with scholars based in Germany, United States and Switzerland. Oliver Planz's co-authors include Stephan Ludwig, Stephan Pleschka, Thorsten Wolff, Christina Ehrhardt, Lothar Stitz, Bianca Dauber, Emanuel Haasbach, Gülşah Gabriel, Hans‐Dieter Klenk and Thomas Bilzer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Oliver Planz

105 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host

2005 557 citations Thorsten Wolff, Oliver Planz et al. profile →

Peers

Countries citing papers authored by Oliver Planz

Since Specialization

Citations

This map shows the geographic impact of Oliver Planz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Planz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Planz more than expected).

Fields of papers citing papers by Oliver Planz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Planz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Planz. The network helps show where Oliver Planz may publish in the future.

Co-authorship network of co-authors of Oliver Planz

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Planz. A scholar is included among the top collaborators of Oliver Planz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Planz. Oliver Planz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patients 2025 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), Martín W. Bauer, Stephan Stenglein, Oliver Pötz, (unknown), (unknown), (unknown), Judith M. A. van den Brand, Geert van Amerongen, Leon de Waal, Stephan Pleschka, Stephan Ludwig, Oliver Planz	0
2	The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance 2024 ·Antiviral Research ·André Schreiber, (unknown), (unknown), Darisuren Anhlan, Stefan Bletz, Alexander Mellmann, Oliver Planz, Stephan Ludwig	12
3	The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs 2022 ·Pharmaceutics ·André Schreiber, (unknown), Oliver Planz, Sebastian Schloer, Ursula Rescher, Stephan Ludwig	16
4	Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron? 2022 ·International Journal of Molecular Sciences ·Ralf Kircheis, Oliver Planz	12
5	Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies 2020 ·EMBO Molecular Medicine ·(unknown), Lisa Walz, Kristina Dietert, (unknown), Oliver Planz, Achim D. Gruber, Veronika von Messling, Thorsten Wolff	24
6	Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection 2016 ·Cerebrovascular Diseases Extra ·Sajjad Muhammad, Oliver Planz, Markus Schwaninger	12
7	Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease 2015 ·Journal of Controlled Release ·(unknown), (unknown), Oliver Planz, Marcus Groettrup	18
8	The NS1 Protein of Influenza A Virus Blocks RIG-I-Mediated Activation of the Noncanonical NF-kappa B Pathway and p52/RelB-Dependent Gene Expression in Lung Epithelial Cells 2013 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·(unknown), Emanuel Haasbach, Ilkka Julkunen, Oliver Planz, Christina Ehrhardt, Stephan Ludwig	1
9	Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro 2013 ·Antiviral Research ·Emanuel Haasbach, (unknown), Oliver Planz	44
10	PAR1 contributes to influenza A virus pathogenicity in mice 2012 ·Journal of Clinical Investigation ·Khaled Khoufache, Fatma Berri, Wolfgang Nacken, Annette B. Vogel, (unknown), Eric Camerer, Shaun R. Coughlin, Peter Carmeliet, Bruno Lina, Guus F. Rimmelzwaan, Oliver Planz, Stephan Ludwig, Béatrice Riteau	72
11	The polyphenol rich plant extract CYSTUS052 is highly effective against H5N1 and pandemic H1N1v influenza A virus 2011 ·OpenAgrar ·Karoline Droebner, Emanuel Haasbach, (unknown), Stephan Ludwig, Oliver Planz	3
12	Low-Dose Interferon Type I Treatment Is Effective Against H5N1 and Swine-Origin H1N1 Influenza A Viruses In Vitro and In Vivo 2011 ·Journal of Interferon & Cytokine Research ·Emanuel Haasbach, Karoline Droebner, Annette B. Vogel, Oliver Planz	33
13	The Alternative NF-κB Signalling Pathway is a Prerequisite for an Appropriate Immune Response Against Lymphocytic Choriomeningitis Virus Infection 2010 ·Viral Immunology ·Karoline Droebner, (unknown), Stephan Paxian, Roland M. Schmid, Lothar Stitz, Oliver Planz	6
14	Borna disease virus: a unique pathogen and its interaction with intracellular signalling pathways 2009 ·Cellular Microbiology ·Oliver Planz, Stephan Pleschka, Thorsten Wolff	14
15	Antibodies and CD4+ T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain 2008 ·Vaccine ·Karoline Droebner, Emanuel Haasbach, (unknown), Andreas O. Weinzierl, Stefan Stevanović, Mathias Büttner, Oliver Planz	27
16	MEK inhibition impairs influenza B virus propagation without emergence of resistant variants 2004 ·FEBS Letters ·Stephan Ludwig, Thorsten Wolff, Christina Ehrhardt, Walter J. Wurzer, Jens Reinhardt, Oliver Planz, Stephan Pleschka	111
17	A Naturally Processed Rat Major Histocompatibility Complex Class I-associated Viral Peptide as Target Structure of Borna Disease Virus-specific CD8+ T Cells 2001 ·Journal of Biological Chemistry ·Oliver Planz, Tilman Dumrese, (unknown), Markus Schirle, Stefan Stevanović, Lothar Stitz	18
18	Lack of antiviral effect of amantadine in Borna disease virus infection 1998 ·Medical Microbiology and Immunology ·Lothar Stitz, Oliver Planz, Thomas Bilzer	23
19	European Swine Virus as a Possible Source for the Next Influenza Pandemic? 1995 ·Virology ·Stephan Ludwig, Lothar Stitz, Oliver Planz, (unknown), W M Fitch, C. Scholtissek	87
20	Lysis of major histocompatibility complex class I-bearing cells in Borna disease virus-induced degenerative encephalopathy. 1993 ·The Journal of Experimental Medicine ·Oliver Planz, Thomas Bilzer, (unknown), Lothar Stitz	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact